Bristol Myers Squibb BMY and Amgen AMGN are among the largest global biotechnology companies with broad and diverse portfolios. Bristol Myers Squibb is focused on discovering, developing and ...

Teens with advanced-stage Hodgkin lymphoma survive longer without their disease getting worse when they receive the ...

Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug Administration earlier this week. In a letter issued on December 15 to Nicole Van ...

Shares of Replimune Group REPL have surged 131.1% over the past three months, fueled by positive regulatory updates. In October, the FDA accepted the resubmission of the biologics license application ...

The type of suppository you need—rectal, vaginal, or urethral—depends on your condition. Suppositories deliver medications directly into your body to treat conditions like constipation or vaginal ...

You may use D-mannose to help prevent UTIs by stopping bacteria from sticking to your urinary tract. It is generally safe for you to take D-mannose for up to six months, but speak with a doctor before ...

One is a sector mainstay that has now raised its payout 17 years in a row. The other is a big player in the animal healthcare space. It's not too late to take advantage of either. The healthcare ...

Bristol-Myers Squibb (BMY) is transitioning from a perceived value trap to a growth-focused, diversified pharmaceutical company. BMY's growth portfolio grew 18% YoY in Q3, offsetting legacy drug ...

Great dividend payers can support and raise their payouts through the years. VICI Properties is a leading REIT with a vast portfolio of experience-oriented properties. Bristol Myers Squibb is a top ...

In vivo CAR T-cell therapies showed promise, with significant developments in partnerships and financing, culminating in a breakthrough for relapsed/refractory multiple myeloma. Precision medicine in ...